Symbol="MIRM"
AssetType="Common Stock"
Name="Mirum Pharmaceuticals Inc"
Description="Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California."
CIK="1759425"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="950 TOWER LANE, SUITE 1050, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="987605000"
EBITDA="-121399000"
PERatio="None"
PEGRatio="None"
BookValue="3.713"
DividendPerShare="0"
DividendYield="0"
EPS="-3.53"
RevenuePerShareTTM="2.703"
ProfitMargin="-1.349"
OperatingMarginTTM="-1.312"
ReturnOnAssetsTTM="-0.257"
ReturnOnEquityTTM="-1.033"
RevenueTTM="95768000"
GrossProfitTTM="64688000"
DilutedEPSTTM="-3.53"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.451"
AnalystTargetPrice="56"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.6"
PriceToBookRatio="3.955"
EVToRevenue="9.3"
EVToEBITDA="-16.18"
Beta="1.266"
num_52WeekHigh="30.55"
num_52WeekLow="17.32"
num_50DayMovingAverage="26.76"
num_200DayMovingAverage="23.42"
SharesOutstanding="38294100"
DividendDate="None"
ExDividendDate="None"
symbol="MIRM"
open="25.84"
high="26.16"
low="25.31"
price="25.76"
volume="488988.00"
latest_trading_day="2023-07-31"
previous_close="25.79"
change="-0.03"
change_percent="-0.1163%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="9"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="91"
Volume_recent_avg="549276"
Change_recent_avg="0.03"
Delta_recent_avg="1.12"
Variance_recent_avg="0.56"
Change_ratio_recent_avg="0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="91"
Aroon_momentum_negative="9"
image_negative_thumbnail_id_1="118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0058.jpeg"
image_negative_thumbnail_id_2="155"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0021.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="581"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_positive_thumbnail_id_1="948"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0110.jpeg"
image_positive_thumbnail_id_2="671"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
